Public reporting burden for this collection of information is estimated to average 1 hour per response, including the time for reviewing instructions, searching existing data sources, gathering and maintaining the data needed, and completing and reviewing this collection of information. Send comments regarding this burden estimate or any other aspect of this collection of information, including suggestions for reducing this burden to Department of Defense, Washington Headquarters Services, Directorate for Information Operations and Reports (0704-0188), 1215 Jefferson Davis Highway, Suite 1204, Arlington, VA 22202-4302. Respondents should be aware that notwithstanding any other provision of law, no person shall be subject to any penalty for failing to comply with a collection of information if it does not display a currently valid OMB control number. PLEASE DO NOT RETURN YOUR FORM TO THE ABOVE ADDRESS. (From -To)
REPORT DATE (DD-MM-YYYY)
01-05-2006
REPORT TYPE
Final
DATES COVERED
PERFORMING ORGANIZATION NAME(S) AND ADDRESS(ES) 8. PERFORMING ORGANIZATION REPORT NUMBERUniversity of Arizona Tucson, Arizona 85722-3308
SPONSORING / MONITORING AGENCY NAME(S) AND ADDRESS(ES) 10. SPONSOR/MONITOR'S ACRONYM(S)
U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland 21702-5012
SPONSOR/MONITOR'S REPORT NUMBER(S)
DISTRIBUTION / AVAILABILITY STATEMENTApproved for Public Release; Distribution Unlimited
SUPPLEMENTARY NOTES
ABSTRACTThe specific aim is to determine if breast cancer cells induce persistent gaps between aged endothelial cells, as compared to "young" endothelial cells, to cause increased cancer cell extravasation and metastasis. The objectives are: 1. To further elucidate the interactions of breast cancer cells with aged endothelial cells using co-cultures, 2. To investigate possible mechanisms of breast cancer cell-induced persistent gap formation in in-vitro aged endothelial monolayers, and 3. To begin examining the relevance of the in-vitro age-related differences in endothelial cell responses to breast cancer cell addition using rat in-vivo aging and metastasis models. In this final report, we find that: 1. Addition of rat breast cancer cells to microvascular endothelial cells harvested from young rats causes transient gaps between endothelial cells, whereas cancer addition to endothelial cells from old rats causes persistent gaps; 2. Early analysis shows that more breast cancer cells transmigrate endothelial cells harvested from young rats; and 3. Though metastases are larger in old rats, compared to young rats, after tail vein injection of cancer cells, differences in immune function may be a confounding factor as cancer cell injection the mammary fat pads causes larger "tumors" in the old rats.
SUBJECT TERMS
IntroductionThe risks for developing and dying from breast cancer increase with age. Death from breast cancer is usually due to metastatic disease. Key events in the metastatic cascade process involve breast cancer cell passage through endothelial cells. In cell culture experiments, w...